(Q33950804)

30 July 2017

1 reference

title

Community respiratory virus infections in immunocompromised patients with cancer (English)

1 reference

30 July 2017

Whimbey E

1

1 reference

30 July 2017

Englund JA

series ordinal

2

1 reference

30 July 2017

Couch RB

series ordinal

3

1 reference

30 July 2017

language of work or name

English

0 references

publication date

1 March 1997

1 reference

American Journal of Medicine

30 July 2017

1 reference

30 July 2017

102

1 reference

30 July 2017

10-8; discussion 25-6

1 reference

30 July 2017

3A

1 reference

Influenza in children and young adults with cancer.20 cases

30 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2980004-6

Adenovirus infections in patients undergoing bone-marrow transplantation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2980004-6

Respiratory syncytial viral infection in children with compromised immune function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2980004-6

Respiratory syncytial virus infection in immunocompromised adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2980004-6

Respiratory syncytial virus infections in adult bone marrow transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2980004-6

Influenza B in transplant patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2980004-6

Respiratory syncytial virus-induced acute lung injury in adult patients with bone marrow transplants: a clinical approach and review of the literature.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2980004-6

Influenza in children with cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2980004-6

An outbreak of respiratory syncytial virus in a bone marrow transplant center

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2980004-6

Adenoviruses in the immunocompromised host

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2980004-6

Influenzal pneumonia as a complication of autologous bone marrow transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2980004-6

Parainfluenza Virus Respiratory Infection after Bone Marrow Transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2980004-6

Influenza A in immunocompromised patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2980004-6

Parainfluenza virus infection in adult bone marrow transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2980004-6

Increasing incidence of adenovirus disease in bone marrow transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2980004-6

Epidemiology of influenza A virus infection in patients with acute or chronic leukemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2980004-6

Respiratory syncytial virus pneumonia in hospitalized adult patients with leukemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2980004-6

Respiratory disease due to parainfluenza virus in adult bone marrow transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2980004-6

Community respiratory virus infections among hospitalized adult bone marrow transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2980004-6

Influenza among hospitalized adults with leukemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2980004-6

Aerosolized ribavirin treatment of infants with respiratory syncytial viral infection. A randomized double-blind study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2980004-6

Studies of passive immunotherapy for infections of respiratory syncytial virus in the respiratory tract of a primate model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2980004-6

Immunoprophylaxis and immunotherapy of respiratory syncytial virus infection in the cotton rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2980004-6

Immunoglobulin administration and ribavirin therapy: efficacy in respiratory syncytial virus infection of the cotton rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2980004-6

Intravenous immunoglobulin treatment of respiratory syncytial virus infections in infants and young children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2980004-6

Prophylactic administration of respiratory syncytial virus immune globulin to high-risk infants and young children. The Respiratory Syncytial Virus Immune Globulin Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2980004-6

Comparison of antibody concentrations and protective activity of respiratory syncytial virus immune globulin and conventional immune globulin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2980004-6

High-dose, short-duration ribavirin aerosol therapy compared with standard ribavirin therapy in children with suspected respiratory syncytial virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2980004-6

Lassa fever. Effective therapy with ribavirin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2980004-6

Prospective, Double-Blind, Concurrent, Placebo-Controlled Clinical Trial of Intravenous Ribavirin Therapy of Hemorrhagic Fever with Renal Syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2980004-6

Influenza immunization of adult patients with malignant diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2980004-6

Antibody response to a two-dose influenza vaccine regimen in adult lymphoma patients on chemotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2980004-6

Prevention of Russian Influenza by Amantadine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2980004-6

Amantadine and ribavirin aerosol treatment of influenza A and B infection in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2980004-6

Ribavirin small-particle aerosol treatment of influenza

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2980004-6

A controlled trial of amantadine and rimantadine in the prophylaxis of influenza A infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2980004-6

Ribavirin Aerosol Treatment of Influenza B Virus Infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2980004-6

Treatment of influenza A (H1N1) virus infection with ribavirin aerosol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2980004-6

Ribavirin small-particle aerosol treatment of infections caused by influenza virus strains A/Victoria/7/83 (H1N1) and B/Texas/1/84.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2980004-6

Oral ribavirin treatment of influenza A and B.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2980004-6

Nebulised ribavirin for influenza B viral pneumonia in a ventilated immunocompromised adult.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2980004-6

The use of intravenous ribavirin to treat influenza virus-associated acute myocarditis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2980004-6

Efficacy and safety of aerosolized ribavirin in young children hospitalized with influenza: a double-blind, multicenter, placebo-controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2980004-6

Emergence and apparent transmission of rimantadine-resistant influenza A virus in families

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2980004-6

Emergence and possible transmission of amantadine-resistant viruses during nursing home outbreaks of influenza A (H3N2).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2980004-6

Prolonged shedding of amantadine-resistant influenzae A viruses by immunodeficient patients: detection by polymerase chain reaction-restriction analysis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2980004-6

Combination antiviral therapy for respiratory virus infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2980004-6

Safety and efficacy of the neuraminidase inhibitor GG167 in experimental human influenza

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2980004-6

Infection control of nosocomial respiratory viral disease in the immunocompromised host

7 January 2021

1 reference

12 December 2020

Nonbacterial Pneumonia After Allogeneic Marrow Transplantation: A Review of Ten Years' Experience

1 reference

12 December 2020

Donor leukocyte infusion as therapy of life-threatening adenoviral infections after T-cell-depleted bone marrow transplantation.

1 reference

12 December 2020

Prophylaxis and treatment of influenza

1 reference

12 December 2020

Effect of cancer chemotherapy on the immune response to influenza virus vaccine: review of published studies

1 reference

12 December 2020

Combination therapy with aerosolized ribavirin and intravenous immunoglobulin for respiratory syncytial virus disease in adult bone marrow transplant recipients

1 reference

12 December 2020

Viral pneumonia in the immunocompromised adult with neoplastic disease: the role of common community respiratory viruses

1 reference

12 December 2020

Children with influenza A infection: treatment with rimantadine.

1 reference

12 December 2020

Respiratory virus infection in immunocompromised patients

1 reference

12 December 2020

Prevention and control of influenza: Recommendations of the Advisory Committee on Immunization Practices (ACIP). Centers for Disease Control and Prevention

1 reference

12 December 2020

Respiratory syncytial virus and parainfluenza virus infections in the immunocompromised host

1 reference

12 December 2020

Immunotherapy of respiratory syncytial virus pneumonia following bone marrow transplantation.

1 reference

12 December 2020

Ribavirin aerosol treatment of influenza

1 reference

12 December 2020

Orthomyxoviral and paramyxoviral infections in transplant patients.

1 reference

12 December 2020

Severe respiratory syncytial virus pneumonia after autologous bone marrow transplantation: a report of three cases and review

1 reference

12 December 2020

Influenza A virus infections among hospitalized adult bone marrow transplant recipients.

1 reference

12 December 2020

Intravenous ribavirin by constant infusion for serious influenza and parainfluenzavirus infection.

1 reference

12 December 2020

Successful therapy with ribavirin of late onset respiratory syncytial virus pneumonitis complicating allogeneic bone transplantation

1 reference

12 December 2020

Respiratory virus infections in bone marrow transplant recipients: the European perspective

1 reference

12 December 2020

Phase I study of intravenous ribavirin treatment of respiratory syncytial virus pneumonia after marrow transplantation

1 reference

12 December 2020

Antibody response to a two-dose regimen of influenza vaccine in allogeneic T cell-depleted and autologous BMT recipients

1 reference

12 December 2020

10.1016/S0002-9343(97)80004-6

Identifiers

DOI

1 reference

30 July 2017

1 reference